Cmps stock forecast.

US20451W1018. Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom. Show more.Another top psychedelic stocks to consider is Field Trip Health. Sine bottoming out at $1.87 in Oct., the stock exploded to a high of $5.50. Now at nearly $3, FTRPF is still worth paying attention ...COMPASS Pathways Stock Forecast and Price Target Year-long price target forecasts from four prominent analysts have recently been released for COMPASS Pathways, with …What this means: InvestorsObserver gives Compass Pathways Plc ADR (CMPS) an overall rank of 34, which is below average. Compass Pathways Plc ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

20 analysts have issued 12-month price objectives for Rivian Automotive's stock. Their RIVN share price targets range from $15.00 to $44.00. On average, they predict the company's stock price to reach $28.95 in the next year. This suggests a possible upside of 60.6% from the stock's current price.

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...The Compass Pathways Plc (CMPS) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $20.62, representing a +291.30% increase from the current price of $5.27. The highest analyst price target is $35.17, and the lowest is $6.0744.

ADRs) share was $6.45 on NAS. Compared to the opening price on Thursday 11/23/2023 on NAS of $6.04, this is a gain of 6.36%.COMPASS Pathways EBIT Forecast for 2023 - 2025 - 2030. In the last year, COMPASS Pathways's EBIT has grown from $-47.15M to $-73.57M – a 56.03% increase. For the following year, the 0 analysts predict that COMPASS Pathways's EBIT will drop by 35.91%, reaching $-47.15M. In 2030, the professionals' prediction is that CMPS's EBIT will decrease ... 3 brokers have issued twelve-month price targets for eXp World's shares. Their EXPI share price targets range from $14.00 to $28.00. On average, they anticipate the company's share price to reach $21.00 in the next year. This suggests a possible upside of 70.9% from the stock's current price. View analysts price targets for EXPI or view top ...You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CMPS scored across 33 valuation, financial, forecast, performance, and dividend due ...The current Compass Pathways PLC [ CMPS] share price is $6.10. The Score for CMPS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. CMPS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Based on analysts offering 12 month price targets for CMPS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Compass Pathways ( CMPS 6.61%) saw its shares drop more than 22% on Tuesday. The biotech stock, which focuses on mental health treatment, closed at $43.06 on Monday, opened at $40.65 on Tuesday ...

ACMR Stock 12 Months Forecast. $24.50. (39.05% Upside) Based on 5 Wall Street analysts offering 12 month price targets for ACM Research in the last 3 months. The average price target is $24.50 with a high forecast of $32.00 and a low forecast of $19.50. The average price target represents a 39.05% change from the last price of $17.62.Farfetch Ltd (NYSE:FTCH) posted its quarterly earnings results on Thursday, November, 18th. The company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by $0.48. The business had revenue of $582.57 million for the quarter, compared to analyst estimates of $591.34 million.CMPS 5.83 USD −0.22 −3.64% Markets / USA / Stocks / Health Technology / Biotechnology / CMPS / Forecast COMPASS Pathways Plc - American Depository …In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.TCON Stock Forecast. With such progress being made, it’s interesting to see what analysts think about TCON stock. The latest forecast from Rob Baird has TRACON at “Buy,” and the firm gave it an $8 target. Based on a previous class of $1.32, that’s 506% higher than current trading levels. List of Penny Stocks To Buy [according to analysts]

COMPASS Pathways has a market cap of $299.3 million, and a 52-week range of $6.74 to $49.52. The stock has a price/book ratio of 1.32, and a price-to-free-cash-flow ratio of -6.9.COMPASS Pathways Stock Forecast All Analysts Top Analysts Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for …LAD Stock 12 Months Forecast. $314.86. (29.84% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Lithia Motors in the last 3 months. The average price target is $314.86 with a high forecast of $455.00 and a low forecast of $220.00. The average price target represents a 29.84% change from the last price of $242.49.For COMPASS Pathways plc stock forecast for 2023, 2 predictions are offered for each month of 2023 with average COMPASS Pathways plc stock forecast of $5.33, a high forecast of $5.36, and a low forecast of $5.3. The average COMPASS Pathways plc stock forecast 2023 represents a 0.88% increase from the last price of $5.28499984741211.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Dec 1, 2023 · According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.

CMPS 5.83 USD −0.22 −3.64% Markets / USA / Stocks / Health Technology / Biotechnology / CMPS / Forecast COMPASS Pathways Plc - American Depository …Innoviz Technologies Ltd. (NASDAQ:INVZ) announced its earnings results on Wednesday, November, 8th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.01. The firm earned $3.48 million during the quarter, compared to the consensus estimate of $3.08 million.Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. 2012. 3,191. Robert Reffkin. https://www.compass.com. Compass, Inc. provides real estate brokerage services in the United States. It operates a cloud-based platform that provides an integrated suite of software for customer relationship management, marketing, client service, operations, and other functionality, as well as brokerage and …Find real-time LLAP - Terran Orbital Corp stock quotes, company profile, news and forecasts from CNN Business.Find real-time LAD - Lithia Motors Inc stock quotes, company profile, news and forecasts from CNN Business.

8 brokers have issued 12-month target prices for CMS Energy's stock. Their CMS share price targets range from $54.00 to $73.00. On average, they expect the company's share price to reach $61.50 in the next year. This suggests a possible upside of 7.3% from the stock's current price.

DXCM Stock 12 Months Forecast. $125.06. (11.53% Upside) Based on 16 Wall Street analysts offering 12 month price targets for Dexcom in the last 3 months. The average price target is $125.06 with a high forecast of $155.00 and a low forecast of $101.00. The average price target represents a 11.53% change from the last price of $112.14.

See the latest Compass Pathways PLC ADR stock price (CMPS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Based on analysts offering 12 month price targets for CMPS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Nov 29, 2023 · According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price. Future criteria checks 0/6. COMPASS Pathways's earnings are forecast to decline at 2.7% per annum while its annual revenue is expected to grow at 82.4% per year. EPS is expected to grow by 6.1% per annum. Return on equity is forecast to be …The current average CMPS price target, as estimated by these analysts, is $0.00. The predictions for the future CMPS stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CMPS.Compare to Open 5.75 Prior Close 5.66 (11/16/23) 1 Day CMPS 6.18% DJIA 0.01% Russell 2K 1.35% Health Care/Life Sciences -0.07% Overview Per-Share Earnings, Actuals & Estimates COMPASS Pathways...Compass Pathways Plc - ADR Stock Price Forecast, "CMPS" Predictons for2023Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.CMPX Stock 12 Months Forecast. $10.50. (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a high forecast of $11.00 and a low forecast of $10.00. The average price target represents a 510.47% change from the last price of $1.72.Company's cash position stands at $248.0 million with a net loss of $33.4 million for Q3 2023. Get the latest COMPASS Pathways plc (CMPS) stock news and headlines to help you in your trading and ... These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, ... Wall Street’s 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS)Find real-time CFLT - Confluent Inc stock quotes, company profile, news and forecasts from CNN Business.

These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, ... Wall Street’s 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS)CMPS Earnings Date and Information. COMPASS Pathways last posted its quarterly earnings data on November 2nd, 2023. The reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by $0.17. COMPASS Pathways has generated ($2.59) earnings per share over the last year ( ($2.59) diluted …Find the latest Cybin Inc. (CYBN) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. nysearca eembest course for pythonlearn to day tradehow to get nft Nov 29, 2023 · The company has $148.49 million in cash and $32.84 million in debt, giving a net cash position of $115.65 million or $1.87 per share. Cash & Cash Equivalents. mondelzclasses on trading stocks The latest COMPASS Pathways stock prices, stock quotes, news, and CMPS history to help you invest and trade smarter. ... COMPASS Pathways Stock Snapshot. 13.44 Bid. 100.00 ... Find the latest Compass Pathways Plc (CMPS) stock forecast, 12-month price target, predictions and analyst recommendations. open bank account instant debit card Illumina Inc Stock Forecast, Predictions & Price Target. Add to Watchlist. Overview Forecast. Earnings Dividend Ownership. Analyst price target for ILMN. All Analysts Top Analysts. Based on 10 analysts offering 12 month price targets for Illumina Inc. Min Forecast. $100.00-8.92%. Avg Forecast. $173.60 +58.12%.Compass Pathways stock indicated to open around $25.00, or 47% above the $17 IPO price. Sep. 18, 2020 at 10:17 a.m. ET by Tomi Kilgore. Compass Pathways PLC Follow Share $5.83 After Hours: $6.12 (4.97%) +0.29 Closed: Nov 21, 6:09:39 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Mind Medicine (MindMed) Inc $2.68 MNMD2.55%...